The Correlation between Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Insulin Resistance and the Components of Atherogenic Lipoprotein Phenotype in Males with Central Obesity
BACKGROUND: Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) promotes the degradation of LDL receptor in hepatocytes. in vitro studies have proven that insulin increases the expression of PCSK9. Insulin resistance, a common condition in central obesity is characterized by dyslipidemia called At...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Secretariat of The Indonesian Biomedical Journal
2010-12-01
|
Series: | Indonesian Biomedical Journal |
Online Access: | http://inabj.org/index.php/ibj/article/view/128 |